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On 1 December 2017, an outbreak of Salmonella Agona 
infections among infants was identified in France. To 
date, 37 cases (median age: 4 months) and two further 
international cases have been confirmed. Five differ-
ent infant milk products manufactured at one facility 
were implicated. On 2 and 10 December, the company 
recalled the implicated products; on 22 December, all 
products processed at the facility since February 2017. 
Trace-forward investigations indicated product distri-
bution to 66 countries.
Identification of the outbreak 
At the end of November 2017 the French National 
Reference Centre (NRC) for Salmonella noted an unusual 
increase in  Salmonella  Agona among infants, with 22 
cases identified between August and November 2017 
in children younger than six months. On 1 December, 
interviews with the caregivers of eight of these infants 
by the French National Institute for Public Health (Santé 
Publique France (SPF)) identified infant milk products 
from a single company as a potential source. All but 
one of the first eight investigated cases had consumed 
products manufactured at a single facility operated by 
this company. This facility had previously been asso-
ciated with an outbreak of  Salmonella  Agona in 2005 
[1]. An outbreak investigation is currently ongoing in 
conjunction with the NRC, SPF, the Ministry of Health 
and the Ministry of Economy in charge of consumers’ 
affairs.
Epidemiological investigations 
The operational definition for probable cases as at 
11 January 2018 includes children younger than two 
years with a laboratory-confirmed  Salmonella  Agona 
infection and with a date of onset of symptoms since 1 
January 2017. A confirmed case is a probable case with 
a  Salmonella  Agona isolate belonging to the outbreak 
cluster by whole genome sequencing (WGS) or, if WGS 
has not been performed, an isolate which does not 
produce H2S and gas after 18 h incubation on Kligler 
iron agar (see Microbiological investigations for further 
details). Cases were excluded if they had a history of 
travel abroad in the 7 days before symptom onset and 
probable cases were excluded if after WGS, they were 
not within the outbreak cluster.
As at 11 January 2018, 37 cases have been identified in 
France, all of whom were confirmed (Figure 1). All cases 
had gastrointestinal symptoms, and there was no case 
of bloodstream infection or meningitis. Almost all cases 
had diarrhoea (34 cases), 23 had bloody diarrhoea, 26 
fever and 13 vomiting. One case had symptom onset 
in April while the remaining cases had onset of symp-
toms between mid-August and 2 December. The cases 
included 21 girls and 16 boys. The median age was 4 
months (range: 2 weeks–9 months). The cases were 
scattered across 10 different regions of France. 
Among 36 cases whose caregivers have been inter-
viewed to date, 18 were hospitalised for their illness, 
all of whom have recovered at the time of writing this 
report. Eleven cases had underlying medical condi-
tions. These conditions were not associated with an 
increased risk of salmonellosis. However, they may 
have increased the likelihood of presentation to a 
healthcare provider and of diagnostic investigations. 
In the 3 days before symptom onset, 35 of the 36 cases 
had consumed infant milk products intended for babies 
aged 0–6 months manufactured by the same company. 
Five different products have been implicated to date: 
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one product was associated with 26 cases (MILK-A), 
one product was associated with five cases (MILK-B), 
one product was associated with two cases (MILK-E) 
and two products were associated with one case each 
(MILK-C and MILK-D). All products were manufactured 
at the same facility. In one confirmed case, exclusive 
breast-feeding was reported.
No other common foods or drinks were identified among 
cases. Given the young age of the cases, the majority 
were still exclusively fed with infant milk products. A 
variety of types of water (tap and different brands of 
bottled water) were used to prepare these products. 
Caregivers were questioned on their practices in rela-
tion to the preparation of bottles of milk (e.g. advance 
preparation, storage, cleaning of equipment) and no 
issues were identified which would increase the risk of 
bacterial contamination or bacterial propagation.
Microbiological investigations 
WGS of  Salmonella  isolates has been performed 
routinely at the French NRC since April 2017. DNA 
extraction, libraries and high-throughput genome 
sequencing for our cases were carried out at PIBnet, 
Institut Pasteur, Paris on the Illumina NextSeq500 
platform. Molecular serotyping was done by in-house 
scripts based on MLST-7, fliC and fliB gene databases. 
For all 88 S. Agona isolates received in the NRC between 
1 January and 31 December 2017, the filtered paired-
end reads were aligned with the Agona SL483 refer-
ence genome (GenBank accession number NC_011149) 
[2]. Phylogenetic analysis was performed on the sin-
gle nucleotide polymorphism (SNP) filtered alignment 
using the maximum-likelihood method, and the final 
tree was visualised as previously described [3]. Raw 
reads of a representative strain are available under the 
European Nucleotide Archive number ERR2219379 and 
under Enterobase name SAL_NA11229AA.
The phylogenetic analysis of all 88 genomes of S. Agona 
human isolates indicated a unique ST13 type with a 
high number of 9,519 SNPs in total and revealed that 
outbreak isolates clustered within a maximum distance 
of 26 SNPs (Figure 2). 
Interestingly, distinctive microbiological traits were 
also found in the outbreak strain: it did not pro-
duce H2S and gas in 18 h incubation on Kligler iron 
agar. Salmonella isolates do typically produce H2S and 
gas in 18 h incubation on Kligler iron agar.
To date, 36 of the 37 confirmed cases belonged to 
this SNP cluster on WGS. For the remaining case, WGS 
results are pending but the isolate does not produce 
H2S and gas after 18 h incubation on Kligler iron agar.
Environmental and product investigations 
Environmental and product investigations by the com-
pany and the Ministry responsible for consumers’ 
affairs are still ongoing. However, epidemiological 
information strongly suggests products manufactured 
at one facility as the source of infections. The facility 
manufactures a wide range of infant and toddler foods. 
Routine microbiological tests of products undertaken 
by the facility as part of normal production practices 
were negative. On 2 December 2017, the company vol-
untarily recalled batches of the three initially implicated 
products (MILKS-A, B, C) [4]. On 10 December, after 
parents of one case reported exclusive use of a fourth 
product (MILK-D), and in light of preliminary results of 
environmental investigations at the facility, the com-
pany recalled all products manufactured at the facility 
since mid-February 2017 and for which production was 
associated with one drying tower at the facility [5,6]. 
On 13 December, five further batches omitted from the 
recall list issued on 10 December were recalled [7]. On 
22 December, as a precautionary measure, the com-
pany voluntarily recalled all products manufactured or 
processed in the facility since February 2017 [6].
Potential for international spread and 
international alerts 
As at 8 January 2018, trace-forward investigations indi-
cated that recalled products were distributed to 66 
countries, including 12 countries in the European Union 
(EU). An alert was issued on the European Rapid Alert 
System for Food and Feed (RASFF) on 4 December, and 
updated as further information on the international dis-
tribution network of the products became available [8]. 
Figure 1
Epicurve of Salmonella Agona confirmed cases in infants by week of diagnosis at the National Reference Centre, France, 
2017 (n = 37)
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The alert was also issued through the Infosan network 
operated by the World Health Organization. European 
public health authorities and microbiologists were 
alerted about the outbreak on 6 December 2017 by SPF 
via an  urgent inquiry  for information issued through 
the Epidemic Intelligence Information System for Food 
and Waterborne Diseases and Zoonoses hosted by the 
European Centre for Disease Prevention and Control.
To date, two cases in infants who consumed impli-
cated exported products have been identified in EU 
countries other than France. The isolate from a case 
in Spain belonged to the outbreak SNP cluster in WGS 
performed at the NRC (data not shown in Figure 2). The 
isolate from a case in Greece did not produce H2S or 
gas after 18 h incubation on Kligler iron agar, and the 
results of WGS are pending [9].
Control measures in France 
In France, multiple media platforms have been used 
since 2 December 2017, to inform parents and caregiv-
ers about the outbreak, to advise them not to use the 
implicated products and to recommend appropriate 
hygiene practices when preparing infant milk prod-
ucts [5]. All recalled products have been published 
on the website of the French ministry responsible for 
consumers’ affairs [4-7]. As the initial public alert was 
issued on a weekend, advice was also given on how 
to mitigate the risk if alternative products were una-
vailable over the weekend. In cooperation with the 
French Society of Paediatrics, advice was issued on 
alternative infant milk product options [10]. The French 
Ministry of Health put in place a telephone help service 
for concerned parents and caregivers. Paediatric and 
maternity facilities as well as healthcare professionals 
were also informed.
Discussion 
In France, surveillance of  Salmonella  infections 
is undertaken by the NRC and SPF. Between 2011 
and 2016,  Salmonella  Agona accounted for 2.1% 
of Salmonella isolates identified in infants and received 
in the NRC, with between eight and 13 isolates received 
by the NRC a year. The detection of eight isolates 
Figure 2
Phylogenetic tree of Salmonella Agona strains received at the National Reference Centre, France, 2017 (n = 88)
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S. Agona genomes were mapped against the ST13 SL483 reference strain [2] using Bowtie2 software and filtering low-quality single nucleotide 
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of  Salmonella  Agona in infants within a period of 8 
days alerted the NRC to the outbreak. No increase in 
the number of Salmonella Agona isolates was observed 
in other age groups. Prompt investigation provided 
strong epidemiological evidence pointing to infant milk 
products manufactured by the same company as the 
source of the outbreak.
This is the third outbreak of  Salmonella  associated 
with infant milk products reported in France [1,11]. 
Similar outbreaks have also been reported elsewhere 
[12-16]. A  Salmonella  Agona outbreak affecting 141 
confirmed cases occurred in France in 2005 and was 
associated with two different products manufactured 
within the same facility implicated in the current out-
break [1]. During the 2005 outbreak, samples of the 
implicated products and environmental samples from 
the facility yielded isolates with the same PFGE pat-
tern as the clinical isolates. However, only one of 176 
and four of 27 samples from the two implicated food 
products and six of 420 environmental samples tested 
positive for  Salmonella  Agona, suggesting a low level 
contamination. The production dates of the positive 
food samples suggested a persistent environmental 
contamination. The source of the contamination in the 
facility was not identified. In the current outbreak, the 
environmental investigations are still ongoing, and 
at this stage no obvious source of contamination has 
been identified within the facility.
The number of cases associated with this outbreak is 
probably underestimated as cases with mild symptoms 
may not have consulted a healthcare professional or 
had comprehensive diagnostic investigations (stool 
sample, culture, identification of serotype, confirma-
tion at the NRC). Despite this possibility, given the 
wide distribution of products and the small number 
of reported cases, the level of contamination of prod-
ucts is probably low. The fact that the current outbreak 
involves the same serotype as the previous outbreak 
raises the question whether the organism has per-
sisted in the facility for 12 years. The persistence 
of Salmonella Agona in a dry food production environ-
ment in the United States, resulting in two outbreaks 10 
years apart, 1998 and 2008, has been reported before 
[17]. Comparison of human and environmental isolates 
from 2005 with isolates from the current outbreak is 
ongoing to investigate this possibility.
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